{"id":82012,"date":"2020-02-12T16:15:49","date_gmt":"2020-02-12T19:15:49","guid":{"rendered":"https:\/\/megalabs.global\/eng\/?p=82012"},"modified":"2020-04-13T19:14:11","modified_gmt":"2020-04-13T22:14:11","slug":"etanercept-biosimilar","status":"publish","type":"post","link":"https:\/\/megalabs.global\/eng\/etanercept-biosimilar\/","title":{"rendered":"Primer biosimilar de Etanercept en Argentina"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><p>[vc_row row_height_percent=&#8221;0&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;2&#8243; top_padding=&#8221;3&#8243; bottom_padding=&#8221;3&#8243; overlay_alpha=&#8221;100&#8243; gutter_size=&#8221;3&#8243; shift_y=&#8221;0&#8243; row_height_use_pixel=&#8221;&#8221;][vc_column column_width_use_pixel=&#8221;yes&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; medium_width=&#8221;0&#8243; zoom_width=&#8221;0&#8243; zoom_height=&#8221;0&#8243; column_width_pixel=&#8221;800&#8243;][vc_column_text]AMEGA Biotech, representante de Megalabs en Argentina, elabora principios activos biotecnol\u00f3gicos en las plantas de producci\u00f3n ubicadas en las provincias de Buenos Aires y Santa Fe, acompa\u00f1adas por las plataformas de desarrollo, estudios pre-cl\u00ednicos y cl\u00ednicos y control de calidad.<\/p>\n<p>En Marzo de 2019, AMEGA Biotech lanz\u00f3 al mercado Enerceptan\u00ae (Enerceptan) un medicamento de origen biotecnol\u00f3gico indicado, entre otras enfermedades, para el tratamiento de la Artritis Reumatoidea (AR), produciendo una sustancial mejora de los signos y s\u00edntomas en pacientes que, principalmente en plena edad productiva, ven altamente afectada su funci\u00f3n f\u00edsica.<u><\/u><u><\/u><\/p>\n<p>El producto demostr\u00f3 la biosimilaridad con el producto de referencia en la comparabilidad anal\u00edtica y en los estudios pre-cl\u00ednicos y cl\u00ednicos desarrollados por la compa\u00f1\u00eda.<u><\/u><u><\/u><\/p>\n<p>Los productos biosimilares no solo impactan significativamente en la reducci\u00f3n de costos de atenci\u00f3n m\u00e9dica sino que tambi\u00e9n tienen un alto impacto social y en la calidad de vida de los pacientes. La obtenci\u00f3n del registro de este producto marca un hito para AMEGA Biotech y la industria argentina, siendo el primer biosimilar de Etanercept en ser aprobado en el pa\u00eds.<u><\/u><u><\/u><\/p>\n<p>Enerceptan\u00aese comercializa en sus presentaciones de 25 Mg y 50Mg en jeringas prellenas para inyecci\u00f3n subcut\u00e1nea.[\/vc_column_text][\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;40&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;2&#8243; top_padding=&#8221;0&#8243; bottom_padding=&#8221;0&#8243; back_color=&#8221;color-877404&#8243; overlay_alpha=&#8221;0&#8243; gutter_size=&#8221;3&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; row_height_use_pixel=&#8221;&#8221; css=&#8221;.vc_custom_1581606360088{margin-top: 50px !important;}&#8221; shape_dividers=&#8221;&#8221;][vc_column column_width_percent=&#8221;100&#8243; position_vertical=&#8221;middle&#8221; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; override_padding=&#8221;yes&#8221; column_padding=&#8221;2&#8243; style=&#8221;dark&#8221; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; medium_width=&#8221;0&#8243; zoom_width=&#8221;0&#8243; zoom_height=&#8221;0&#8243; width=&#8221;1\/1&#8243;][vc_custom_heading heading_semantic=&#8221;h6&#8243; text_font=&#8221;font-195522&#8243; text_size=&#8221;h1&#8243; text_weight=&#8221;400&#8243; sub_lead=&#8221;yes&#8221; sub_reduced=&#8221;yes&#8221; text_uppercase=&#8221;&#8221;]<span class=\"font-195522\">\u00a0La obtenci\u00f3n del registro de este producto marca un hito para AMEGA Biotech y la industria argentina, siendo el primer biosimilar de Etanercept en ser aprobado en el pa\u00eds.<\/span>[\/vc_custom_heading][\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;0&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;2&#8243; top_padding=&#8221;3&#8243; bottom_padding=&#8221;3&#8243; overlay_alpha=&#8221;100&#8243; gutter_size=&#8221;3&#8243; shift_y=&#8221;0&#8243; row_height_use_pixel=&#8221;&#8221;][vc_column column_width_use_pixel=&#8221;yes&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; medium_width=&#8221;0&#8243; zoom_width=&#8221;0&#8243; zoom_height=&#8221;0&#8243; column_width_pixel=&#8221;800&#8243;][vc_column_text]<b>ETANERCEPT<\/b><\/p>\n<p>Etanercept pertenece a una clase de medicamentos llamados inhibidores del factor de necrosis tumoral (TNF). Act\u00faa bloqueando la acci\u00f3n del TNF, una sustancia del cuerpo que provoca inflamaci\u00f3n.<\/p>\n<p>Etanercept se usa solo o en combinaci\u00f3n con otros medicamentos para aliviar los s\u00edntomas de determinados trastornos autoinmunes (afecciones en las que el sistema inmunitario ataca las partes sanas del cuerpo y provoca dolor, inflamaci\u00f3n y da\u00f1os). Entre estos se encuentran: artritis reumatoide, artritis reumatoidea activa con artritis psori\u00e1sica, artritis idiop\u00e1tica juvenil poliarticular, espondilitis anquilosante, psoriasis cr\u00f3nica en placas .[\/vc_column_text][\/vc_column][\/vc_row][vc_row unlock_row=&#8221;&#8221; row_height_percent=&#8221;0&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;2&#8243; top_padding=&#8221;3&#8243; bottom_padding=&#8221;3&#8243; overlay_alpha=&#8221;100&#8243; gutter_size=&#8221;3&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; row_height_use_pixel=&#8221;&#8221;][vc_column column_width_use_pixel=&#8221;yes&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; medium_width=&#8221;0&#8243; zoom_width=&#8221;0&#8243; zoom_height=&#8221;0&#8243;][vc_single_image media=&#8221;82024&#8243; media_width_use_pixel=&#8221;yes&#8221; alignment=&#8221;center&#8221; media_title_uppercase=&#8221;&#8221; media_width_pixel=&#8221;800&#8243;][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>AMEGA Biotech, representante de Megalabs en Argentina, lanz\u00f3 al mercado Enerceptan\u00ae un medicamento de origen biotecnol\u00f3gico fruto de un desarrollo propio<\/p>\n","protected":false},"author":1,"featured_media":82027,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[58],"tags":[69,56,68],"class_list":["post-82012","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-development","tag-biosimilares","tag-id","tag-innovacion"],"_links":{"self":[{"href":"https:\/\/megalabs.global\/eng\/wp-json\/wp\/v2\/posts\/82012","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/megalabs.global\/eng\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/megalabs.global\/eng\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/megalabs.global\/eng\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/megalabs.global\/eng\/wp-json\/wp\/v2\/comments?post=82012"}],"version-history":[{"count":0,"href":"https:\/\/megalabs.global\/eng\/wp-json\/wp\/v2\/posts\/82012\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/megalabs.global\/eng\/wp-json\/wp\/v2\/media\/82027"}],"wp:attachment":[{"href":"https:\/\/megalabs.global\/eng\/wp-json\/wp\/v2\/media?parent=82012"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/megalabs.global\/eng\/wp-json\/wp\/v2\/categories?post=82012"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/megalabs.global\/eng\/wp-json\/wp\/v2\/tags?post=82012"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}